SCTB14

· Sinocelltech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCTB14, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer. [Phase 3]

See pricing